Clinicopathological Characteristics, Treatment, and Prognosis of 21 Patients with Primary Gastric Squamous Cell Carcinoma
Table 1
Clinicopathological characteristics and demographical data of 21 patients with PGSCC.
Number
Gender
Age
PS score
Site
Size (cm)
Borrmann type
HGB
ALB
Ca
1
m
48
1
Gastric body (M)
5.8
I
51
32
2.02
2
f
48
1
Gastric body (M)
15
I
102
33.6
2.17
3
f
72
1
Gastric antrum (L)
5
II
141
35
1.98
4
m
52
1
Gastric body (M)
6
III
87
26.5
1.87
5
m
61
3
Gastric body (M)
5.6
I
58
28.9
1.89
6
m
67
3
Fundus of stomach (U)
7.3
I
87
36.5
2.05
7
m
61
0
Fundus of stomach (U)
8
I
82
28.7
2.04
8
m
59
1
Fundus of stomach (U)
5
I
90
41.3
2.16
9
m
68
1
Fundus of stomach (U)
8
II
118
41.1
2.25
10
f
67
2
Fundus of stomach (U)
9
III
118
36.9
1.88
11
m
75
0
Gastric cardia (U)
4
III
123
41.1
2.14
12
m
68
1
Gastric cardia (U)
5
II
167
43.3
2.29
13
m
63
0
Gastric body (M)
4
II
127
40
2.19
14
m
67
1
Gastric body (U)
8
I
90
35.8
2.20
15
m
67
1
Gastric cardia (U)
4.5
II
110
31.5
1.93
16
m
67
1
Gastric cardia (U)
7
II
112
34.7
2.22
17
m
48
1
Gastric cardia (U)
3
I
135
39.9
2.16
18
m
65
1
Gastric cardia (U)
3
I
111
43.7
2.17
19
m
69
1
Gastric cardia (U)
8
III
150
27.8
2.00
20
m
73
2
Gastric body (M)
9.5
I
109
33.8
2.10
21
m
55
1
Fundus of stomach (U)
4
III
152
42.1
2.27
PGSCC: primary gastric squamous cell carcinoma; m: male; f: female; PS score: performance status score; U: upper third of stomach; M: middle third of stomach; L: lower third of stomach; normal range: 120–160 g/L; normal range: 35–55 g/L; normal range: 2.1–2.7 mmol/L.
